China Pharma Holdings (CPHI) Invested Capital (2010 - 2026)

China Pharma Holdings (CPHI) has reported Invested Capital for 17 consecutive years, with $39.8 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Invested Capital rose 275.45% year-over-year to $39.8 million; the trailing twelve-month figure through Jun 2026 stood at $39.8 million (up 275.45% YoY), and the FY2025 full-year result was $26.2 million, up 128.82% from the prior year.
• Invested Capital fell to $39.8 million in Q2 2026 per CPHI's latest filing, from $40.4 million in the prior quarter.
• Across five years, Invested Capital topped out at $40.4 million in Q1 2026 and bottomed at $7.3 million in Q2 2022.
• Historically, Invested Capital has averaged $14.6 million across 5 years, with a median of $10.7 million in 2023.
• The sharpest annual moves came in 2022 and 2026: Invested Capital fell 22.56% in 2022, then soared 278.83% in 2026.
• Over 5 years, Invested Capital stood at $10.5 million in 2022, then gained by 5.73% to $11.1 million in 2023, then rose by 2.65% to $11.4 million in 2024, then jumped by 128.82% to $26.2 million in 2025, then jumped by 52.13% to $39.8 million in 2026.
• According to Business Quant data, Invested Capital over the past three periods registered $39.8 million, $40.4 million, and $26.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.